Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester

NCT00287417 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2011-05-16

No results posted yet for this study

Summary

The aim of the study is to evaluate the risk of Down syndrome during the first trimester of the pregnancy. The risk assessment is evaluated using early ultrasound and maternal biochemical markers.

Conditions

  • Down Syndrome

Interventions

DEVICE

echography

OTHER

blood sample

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Principal Investigators

  • Israel Nisand, MD · Hopitaux Universitaires de Strasbourg

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-07-31
Completion
2011-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00287417 on ClinicalTrials.gov